

























Autophagy is a critical catabolic process through which 
cytoplasmic components are degraded, with the primary 
purpose of removing long-lived and/or damaged 
proteins and organelles and recycling essential anabolic 
building-block molecules [1]. Mechanistically, this 
involves formation of autophagosomes that are fused 
with lysosomes to facilitate digestion of the internalized 
components by lysosomal proteases. Proteins that 
mediate specific steps of the autophagy pathway have 
been characterized, mutations in which cause severe 
disease pathology affecting tissues such as muscle, 
brain, heart, liver and the immune system [2].  In 
addition, defects in autophagy are associated with aging 
and age-related pathology in yeast, worm and fly model 
organisms [3-6].   
 
In mammals, autophagy is essential, as demonstrated by 
neonatal lethality of specific gene knock-outs of 
proteins required for the process, underscoring its 
importance in cell homeostasis, as well as organismal 
growth and development [1].  Conditional and tissue-
specific knock-out of genes involved in autophagy in 
mice have provided more detailed insight into this 
process.  For example, such approaches have uncovered 
that impaired autophagy results in phenotypes and 
pathology that are commonly observed during the 
normal aging process [1].  While the precise underlying 
mechanisms  driving  autophagy-related  pathology   re- 
 
 
                                                                     Preview  











































main obscure, the study of Finkel and colleagues  (Wu 
et al.,  in this issue of Aging)  provides critical new 
insight by showing that mitochondrial dysfunction is 
likely a critical precipitating factor. 
 
In their study, Wu et al. show that impairment of 
autophagy, via deletion of the Atg7 gene that is 
essential for the process, profoundly influences 
mitochondrial function.  In a skeletal muscle-specific 
Atg7 knock-out, ultra-structural abnormalities in 
mitochondria are observed, as is decreased basal and 
maximal respiration due to impairments of complex I 
and II activity.  This result was largely reproduced in 
mouse embryonic fibroblasts from Atg7-/- embryos, 
which also display markedly reduced basal respiratory 
activity and total mitochondrial oxidative capacity. 
These effects appear to be levied at the level of 
respiration activity directly, as opposed to through 
effects on overall mitochondrial biogenesis, because no 
differences in the amounts of assembled oxidative 
phosphorylation complexes or amount of mtDNA/cell 
(a common measure of mitochondrial abundance) were 
observed.  The lack of an overt physiological phenotype 
in the skeletal muscle of these mice appears to be due, 
at least in part, to a compensatory increase in glycolysis.  
Importantly, the lower mitochondrial respiratory 
activity is associated with an increase in steady-state 
levels of cellular reactive oxygen species (ROS).  It 
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increased mitochondrial ROS production, a decrease in 
cellular antioxidant defenses, or both.  Nonetheless, Wu 
et al. demonstrate that treatment of Atg7-/- MEFs with 
the antioxidant N-acetylcysteine (NAC) reverts the 
mitochondrial phenotypes, both in terms of respiration 
and ROS.  Perhaps as expected, the antioxidant 
treatment did not restore autophagy per se, suggesting 
that ROS are key downstream mediators of 
mitochondrial dysfunction in the absence of autophagy.  
This conclusion is bolstered by the recent study by Tal 
et al. [7], who also showed that ROS are downstream 
mediators of impaired autophagy.  However, in this 
case, lack of autophagy due to Atg5 knock-out results in 
ROS-dependent enhancement of innate antiviral 
signaling (i.e. RLR signaling) and interferon production 
and, consequently, the beneficial effect of providing 
resistance to a viral infection.  Together, these two 
studies highlight 1) the complex and tissue-specific role 
that ROS play in cells, acting as both signaling 
molecules and mediators of oxidative damage and 2) 
that perturbation of ROS homeostasis is a key cellular 
event that follows down-regulation of autophagy. 
 
In their study, Wu et al. also created mice with 
pancreatic β-cell-specific deletion of Atg7.  While the 
insulin expression and the overall cellular structure of 
the pancreatic islets in these mice at 8-weeks of age are 
largely unperturbed, abnormal mitochondrial morpho-
logy and respiration are apparent. This is accompanied 
by oxidative stress and the previously described 
disturbance of glucose tolerance and insulin secretion.  
Similar to the results obtained in autophagy-minus 
skeletal muscle, Wu and colleagues found that in vivo 
NAC treatment reverted the oxidative stress-related 
phenotypes in β-cells lacking autophagy, while not 
reverting the autophagy defect per se.  In addition, NAC 
treatment also corrected the glucose tolerance and 
insulin secretion defects, again implicating ROS as a 
central downstream mediator of the cellular and 
physiological responses to faulty autophagy. 
 
While the study of Wu et al., and others [7] solidify the 
role of ROS in mediating the effects of debilitated 
autophagy, it is likely that other mitochondrial-derived 
mediators (e.g. calcium, ATP/ADP, other metabolites) 
are involved. And, as pointed out by Wu et al., these are 
likely to be tissue-specific and/or different depending 
on the specific defect in the autophagic machinery that 
is causative.  Furthermore, it is important to stress that 
the work of Finkel and colleagues demonstrates that 
mitochondrial abnormalities occur at a very early stage, 
when no pathology is yet evident in the tissues, which 
very likely places mitochondrial perturbations at the 
core of the disease pathology caused by certain 
autophagy defects.  It will be of great interest to deter-
mine if mitochondrial signals (ROS or otherwise) are 
instructive in promoting the up-regulation of glycolysis 
and other metabolic alterations and which signaling 
pathways are reading out these directly.  In this regard, 
the role of the nutrient-sensing, target of rapamycin 
(TOR) pathway in responding to and controlling 
mitochondrial respiration [8-11] is intriguing, especially 
since TOR kinase also has its hands in controlling 
autophagy [12] and is potentially a redox-sensitive 
enzyme that could directly respond to altered ROS [13]. 
 
Finally the study by Wu et al. opens many new avenues 
of future investigation that could have a positive impact 
on potential therapeutic routes for autophagy-related 
diseases and age-related pathology. Certainly, their 
results suggest that antioxidant treatment may be a 
viable option to pursue further. This, however, is likely 
to be a slippery slope given the aforementioned 
signaling role for ROS.  That is, antioxidants may be 
valuable for extreme cases of oxidative stress-related 
pathology, but may, at the same time, perturb other 
pathways in unpredictable ways that could cause 
unwanted side effects. In a larger context, the Wu et al. 
study joins a rapidly growing list that shows mito-
chondrial dysfunction lies at the center of not only rare 
metabolic diseases, but also common ailments that 
plague our society such as diabetes, heart disease, 
neurodegenerative disorders, and age-related pathology.  
Determining the nature of the connections between 
mitochondrial dysfunction, ROS and pathogenic 
mechanisms is a burgeoning area of great importance.  
Precise modulation of the autophagy pathway appears 
to be a novel route toward understanding these 
connections and perhaps for devising much-needed new 
therapeutic solutions. 
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